CRYSTALILLE Cohort: Getting the Whole Picture of Crystal-related Arthropathies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLille Catholic University
About this trial
The objective of this research is to collect data to create an observatory of microcrystalline rheumatism (gout and calcium-crystal rheumatism) in patients treated at the Groupement des Hôpitaux de l'Institut Catholique de Lille, in order to better understand the disease and improve patient care, in particular with the help of medical imaging.
Eligibility criteria
Qualifiers
Diagnosis of gout according to American College of Rheumatology /European League Against Rheumatism (ACR/EULAR) 2015 criteria OR diagnosis of calcium pyrophosphate dihydrate crystal deposition disease (CPPD) based on EULAR 2011 recommendations OR diagnosis of hydroxyapatite crystal rheumatism (HCR) according to a typical clinical sequence and demonstration of compatible calcium deposits on imaging
patient who will benefit or has benefited from an ultrasound and/or DECT evaluation of microcrystalline deposits
clinical suspicion of microcrystalline rheumatism requiring further imaging to confirm the diagnosis
Disqualifiers
Refusal or contra-indication to perform ultrasound or dual energy scanning.
Patient's opposition to the use of his or her health data for research purposes
Patient under guardianship or curatorship
Pregnant woman
Trial design
Treatments tested in this trial
- Data collection
Treatment groups
1,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov